한미 FTA 저지 지적재산권 분야 대책위원회

http://www.democrats.reform.house.gov/Documents/20050609094902-11945.pdf

미국 민주당 하원 의원 Waxman 의원실의 보고서 입니다. 결론은 아래와 같습니다.

In 2001, the United States joined the international community in adopting the Doha Declaration, which recognized that trade agreements should not impede the efforts of developing nations to obtain essential drugs at affordable prices. Since then, the Bush Administration has negotiated multiple trade agreements with developing nations, including the CAFTA agreement now pending before Congress. Contrary to the principles of the Doha Declaration, the Administration has used these trade agreements to restrict the access of developing nations to
low-cost generic drugs. By delaying generic drug approvals, extending patent terms, limiting compulsory licensing, prohibiting parallel importation, and otherwise restricting countries’ efforts to improve access to affordable drugs, the trade agreements undermine the safeguards outlined in the Doha Declaration.

These agreements may offer advantages to multinational pharmaceutical companies, but they do so at a serious cost to public health in the developing nations.